AI assistant
Sending…
IO Biotech, Inc. — Director's Dealing 2022
Oct 19, 2022
34883_dirs_2022-10-19_94d4971a-f827-4a45-bb51-40bd41544499.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: IO Biotech, Inc. (IOBT)
CIK: 0001865494
Period of Report: 2022-10-15
Reporting Person: Sullivan Amy (Chief Financial Officer)
More from IO Biotech, Inc.
Board/Management Information
2026
Mar 31
Delisting Announcement
2026
Feb 13
Major Shareholding Notification
2026
Feb 13
Major Shareholding Notification
2026
Feb 6
Regulatory Filings
2026
Jan 30
Major Shareholding Notification
2026
Jan 23
Regulatory Filings
2026
Jan 21
Delisting Announcement
2025
Dec 19
Board/Management Information
2025
Nov 21
Investor Presentation
2025
Nov 18